ABBOTT LABORATORIES — Board/Management Information 2012

Jun 1, 2012

8-K/A 1 a12-13499_18ka.htm 8-K/A

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*WASHINGTON, D.C. 20549*

*FORM 8-K/A*

*(Amendment No. 1)*

*CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): June 1, 2012 (April 27, 2012)

*ABBOTT LABORATORIES*

(Exact name of registrant as specified in its charter)

Illinois	1-2189	36-0698440
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

*100 Abbott Park Road*

*Abbott Park, Illinois 60064-6400*

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (847) 937-6100

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\jmathew\12-13499-1\task5380806\13499-1-ba.htm',USER='105205',CD='Jun 1 06:49 2012'

*Item 5.02 — Departure of Directors or Certain Officers*

Effective June 1, 2012, Brian J. Blaser is Abbott’s Executive Vice President, Diagnostic Products, replacing Edward L. Michael, whose previously-announced retirement will be effective June 30, 2012.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\jmathew\12-13499-1\task5380806\13499-1-ba.htm',USER='105205',CD='Jun 1 06:49 2012'

*Signatures*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 1, 2012
By:	/s/ Thomas C. Freyman
	Thomas C. Freyman
	Executive Vice President,
	Finance and Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\jmathew\12-13499-1\task5380806\13499-1-ba.htm',USER='105205',CD='Jun 1 06:49 2012'